(R)-(-)-Deprenyl hydrochloride

Pricing Availability Delivery Time Qty
Cat.No. 1095 - (R)-(-)-Deprenyl hydrochloride | C13H17N.HCl | CAS No. 14611-52-0
Description: MAO-B inhibitor
Alternative Names: Selegiline
Chemical Name: (R)-(-)-N-α-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride
Purity: ≥99% (HPLC)
Datasheet
Citations
Literature

Biological Activity

Selective inhibitor of monoamine oxidase B (MAO-B).

Technical Data

M. Wt 223.74
Formula C13H17N.HCl
Storage Store at RT
Purity ≥99% (HPLC)
CAS Number 14611-52-0
PubChem ID 26758
InChI Key IYETZZCWLLUHIJ-UTONKHPSSA-N
Smiles C#CCN(C)[C@H](C)CC1=CC=CC=C1.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
ethanol 22.37 100
water 22.37 100

Preparing Stock Solutions

The following data is based on the product molecular weight 223.74. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 4.47 mL 22.35 mL 44.69 mL
5 mM 0.89 mL 4.47 mL 8.94 mL
10 mM 0.45 mL 2.23 mL 4.47 mL
50 mM 0.09 mL 0.45 mL 0.89 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References

References are publications that support the products' biological activity.

Gerlach et al (1992) The molecular pharmacology of L-deprenyl. Eur.J.Pharmacol. 226 97 PMID: 1639115

Kaseda et al (1999) Effect of selegeline on dopamine concentration in the striatum of a primate. Brain Res. 815 44 PMID: 9974121

Kotake et al (1998) Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies. Brain Res. 787 341 PMID: 9518683

Mercuri et al (1998) Modification of levodopa responses by deprenyl (selegiline): an electrophysiological and behavioural study in the rat relevant to Parkinson's disease. Ann.Neurol. 43 613 PMID: 9585355

Merck Index 12 8569 PMID:


If you know of a relevant reference for (R)-(-)-Deprenyl hydrochloride, please let us know.

View Related Products by Product Action

View all Monoamine Oxidase Inhibitors

Keywords: MAO-B inhibitors inhibits Monoamine Oxygenases Oxidases parkinson's parkinsons Selegiline Monoamine Oxidase

Citations for (R)-(-)-Deprenyl hydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for (R)-(-)-Deprenyl hydrochloride. Do you know of a great paper that uses (R)-(-)-Deprenyl hydrochloride from Tocris? If so please let us know.

Commented out for usability testing

Reviews

TODO: Add Reviews

Literature in this Area

Neurodegeneration

Neurodegeneration Product Guide

A collection of over 275 products for neurodegeneration research, the guide includes research tools for the study of:

  • Alzheimer's disease
  • Parkinson's disease
  • Huntington's disease
Addiction

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's

Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.

Pathways for (R)-(-)-Deprenyl hydrochloride

Protocols

TODO: Add Protocols